This apparent paradox can be explained by the fact that while some tumours develop TGFβ-inactivating mutations and progress in a TGFβ-independent manner [18], others accumulate mutations in tumour suppressor genes that operate downstream of TGFβ signalling. The gene discussed is TGFB1; the disease is neoplasm.